TY  - RPRT
TI  - Nucleophosmin mutations lead to abnormal, but reversible, nucleoli architecture and aggregate formation - implications for NPM1-targeting therapies in AML
AU  - Grundy, M.
AU  - Lucken, K.
AU  - Xing, X.
AU  - Simpson, E. L.
AU  - Bayyoomi, A.
AU  - Beckett, A. J.
AU  - Prior, I. A.
AU  - Booth, D. G.
AU  - Seedhouse, C. H.
PY  - 2024
DO  - 10.1101/2024.12.30.630786
UR  - https://www.biorxiv.org/content/10.1101/2024.12.30.630786v1
ID  - 10.1101/2024.12.30.630786
ER  -